Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature

Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3)

(2011) M. Jager et al.   CANCER RESEARCH

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

Cutaneous Metastasis of Ovarian Carcinoma With Shadow Cells Mimicking a Primary Pilomatrical Neoplasm

(2010) Daniel Lalich et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

(2010) Peter Ruf et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

(2010) Markus M. Heiss et al.   INTERNATIONAL JOURNAL OF CANCER

Extra-abdominal Metastases From Epithelial Ovarian Carcinoma

(2010) Bei Cheng et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Recurrent ovarian malignancy presenting as cutaneous metastasis

(2010) ShilpajaJ Karpate et al.   INDIAN JOURNAL OF DERMATOLOGY

Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

(2009) Michael A Strohlein et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature

(2009) Senem Demirci et al.   MEDICAL ONCOLOGY